MiMedx drove sales of its tissue grafts through means that included ‘channel stuffing,’ and it brooked little criticism, some former employees allege. The company is doing an internal investigation and preparing to restate financial results back to 2012.
from WSJ.com: US Business https://ift.tt/2Lfqa2d
via IFTTT
No comments:
Post a Comment